Nicox SA (Euronext Paris: FR0013018124, COX, PEA-PME eligible), an international company specializing in ophthalmology, today announces its intention to transfer the listing of its shares from the regulated market Euronext Paris to Euronext Growth Paris and, to this end, invites its shareholders to an Ordinary General Meeting for Tuesday February 14, 2023 at 2 p.m., in the offices of BuroClub – Drakkar 2 – Building D – 2405 route des Dolines – 06560 Valbonne. The Ordinary General Meeting will be called upon to rule on the proposed transfer of the listing of securities issued by the Company from the regulated market Euronext Paris to the multilateral trading system Euronext Growth Paris (the “Transfer”) and to give the Board of administration all powers to carry out the said Transfer. Euronext Growth Paris is a market organized by Euronext Paris. It is not a regulated market but an organized multilateral trading facility within the meaning of Article 525-1 of the General Regulations of the Autorité des Marchés Financiers (“AMF”). Its organizational rules are approved by the AMF.